Integrated Filing — IndAS



General information about company
Scrip Code 544432
NSE Symbol IGCL
MSEI Symbol NOTLISTED
ISIN INE05J901018
Name of company Indogulf Cropsciences Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 24-Jul-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 21-Jul-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Agro Chemicals
Start date and time of board meeting 24-Jul-2025   16:00:00
End date and time of board meeting 24-Jul-2025   18:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2024-09-20
Indicate Company website link for updated RPT policy of the Company https://investor.groupindogulf.com/view?file=1727067319846-ICL_RiskPolicy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
The disclosure is not applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 1229180000 5923760000
Other income 21060000 43000000
Total income 1250240000 5966760000
2 Expenses
(a) Cost of materials consumed 1373380000 4553080000
(b) Purchases of stock-in-trade 7850000 103670000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -652890000 -460070000
(d) Employee benefit expense 111570000 446200000
(e) Finance costs 40230000 142330000
(f) Depreciation, depletion and amortisation expense 34030000 104670000
(f) Other Expenses
1 Other Expenses 186640000 636960000
Total other expenses 186640000 636960000
Total expenses 1100810000 5526840000
3 Total profit before exceptional items and tax 149430000 439920000
4 Exceptional items 130000 13490000
5 Total profit before tax 149560000 453410000
6 Tax expense
7 Current tax 59410000 134580000
8 Deferred tax -6800000 -2020000
9 Total tax expenses 52610000 132560000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 96950000 320850000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 96950000 320850000
17 Other comprehensive income net of taxes 550000 1550000
18 Total Comprehensive Income for the period 97500000 322400000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 487870000 487870000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 2275060000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.99 7.16
Diluted earnings (loss) per share from continuing operations 1.99 7.16
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.99 7.16
Diluted earnings (loss) per share from continuing and discontinued operations 1.99 7.16
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 359420000
Capital work-in-progress 570500000
Investment property 0
Goodwill 0
Other intangible assets 110570000
Intangible assets under development 1920000
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 210000
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 6950000
Total non-current financial assets 7160000
Deferred tax assets (net) 0
Other non-current assets 113230000
Total non-current assets 1162800000
2 Current assets
Inventories 2631530000
Current financial asset
Current investments 0
Trade receivables, current 2264450000
Cash and cash equivalents 94060000
Bank balance other than cash and cash equivalents 0
Loans, current 0
Other current financial assets 49660000
Total current financial assets 2408170000
Current tax assets (net) 117650000
Other current assets 492360000
Total current assets 5649710000
3 Non-current assets classified as held for sale 7970000
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 6820480000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 487870000
Other equity 2275060000
Total equity attributable to owners of parent 2762930000
Non controlling interest
Total equity 2762930000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 396420000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 79280000
Total non-current financial liabilities 475700000
Provisions, non-current 23580000
Deferred tax liabilities (net) -24850000
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 474430000
Current liabilities
Current financial liabilities
Borrowings, current 1827440000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 117420000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1214970000
Total Trade payable 1332390000
Other current financial liabilities 252920000
Total current financial liabilities 3412750000
Other current liabilities 26020000
Provisions, current 9770000
Current tax liabilities (Net) 134580000
Deferred government grants, Current
Total current liabilities 3583120000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 4057550000
Total equity and liabilites 6820480000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Unaudited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of net defined benefit plants 730000 2070000
2 Income tax related to these items -180000 -520000
Total Amount of items that will not be reclassified to profit and loss 550000 1550000
2 Income tax relating to items that will not be reclassified to profit or loss 0 0
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income 550000 1550000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 453410000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 142330000
Adjustments for decrease (increase) in inventories -679440000
Adjustments for decrease (increase) in trade receivables, current -50330000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -268540000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current -1420000
Adjustments for other financial assets, current 21020000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 235030000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 6570000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 104670000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 3000000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 45140000
Adjustments for other financial liabilities, non-current 5860000
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 5950000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items -11420000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -453480000
Net cash flows from (used in) operations -70000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 117160000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities -117230000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 420460000
Proceeds from sales of investment property 18300000
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 5950000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) investing activities -396210000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 120000000
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 619380000
Repayments of borrowings 0
Payments of lease liabilities 23980000
Dividends paid 0
Interest paid 137060000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 578340000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 64900000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 64900000
Cash and cash equivalents cash flow statement at beginning of period 29160000
Cash and cash equivalents cash flow statement at end of period 94060000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Devesh Parekh & Co. Yes 29-Feb-2028


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Indogulf Cropsciences Limited Sh. Om Parkash Aggarwal Director Remuneration 19200000 NIL 9600000 990000 990000
2 Indogulf Cropsciences Limited Sh. Sanjay Aggarwal Director Remuneration 19200000 NIL 9600000 770000 770000
3 Indogulf Cropsciences Limited Sh.Pushap Kumar Director Remuneration 10000000 NIL 460000 80000 60000
4 Indogulf Cropsciences Limited Sh. Rahul Gupta Independent Director Any other transaction Setting fees 1200000 NIL 30000 0 0
5 Indogulf Cropsciences Limited Sh. Sandeep Bhutani Independent Director Any other transaction Setting fees 1200000 NIL 30000 0 0
6 Indogulf Cropsciences Limited Smt Uma Verma Independent Director Any other transaction Setting fees 1200000 NIL 10000 10000 0
7 Indogulf Cropsciences Limited Sh Snehal Kashyap Independent Director Any other transaction Setting fees 1200000 NIL 10000 0 0
8 Indogulf Cropsciences Limited Sh Sunil Dutt Independent Director Any other transaction Setting fees 0 NIL 0 10000 0
9 Indogulf Cropsciences Limited Sh. Manoj Gupta Chief Financial Officer Remuneration 2500000 NIL 1140000 140000 120000
10 Indogulf Cropsciences Limited Ms. Sakshi Jain Company Secretary Remuneration 1000000 NIL 320000 50000 50000
11 Indogulf Cropsciences Limited Smt. Anshu Aggarwal Director Any other transaction Factory Rent 10000000 NIL 1350000 0 0
12 Indogulf Cropsciences Limited Smt. Anshu Aggarwal Director Any other transaction Godown Rent 10000000 NIL 480000 0 0
13 Indogulf Cropsciences Limited Smt. Anshu Aggarwal Director Any other transaction Factory Rent 10000000 NIL 180000 0 0
14 Indogulf Cropsciences Limited Smt. Anshu Aggarwal Director Any other transaction Godown Rent 10000000 NIL 1050000 550000 900000
15 Indogulf Cropsciences Limited O.P. Aggarwal(HUF) Director's HUF Any other transaction Factory Rent 10000000 NIL 300000 80000 0
16 Indogulf Cropsciences Limited O.P. Aggarwal(HUF) Director's HUF Any other transaction Office Rent 10000000 NIL 120000 0 0
17 Indogulf Cropsciences Limited Smt. Anshu Aggarwal Director Any other transaction Land Rent 10000000 NIL 30000 0 0
18 Indogulf Cropsciences Limited Sanjay Aggarwal Director Any other transaction Land Rent 10000000 NIL 50000 0 0
19 Indogulf Cropsciences Limited Sanjay Aggarwal Director Any other transaction Land Rent 10000000 NIL 1200000 540000 540000
20 Indogulf Cropsciences Limited Sanjay Aggarwal Director Any other transaction Land Rent 10000000 NIL 1800000 0 0
21 Indogulf Cropsciences Limited Sanjay Aggarwal (HUF) Director's HUF Any other transaction Office Rent 10000000 NIL 3750000 0 0
22 Indogulf Cropsciences Limited Sanjay Aggarwal (HUF) Director's HUF Any other transaction Godown Rent 10000000 NIL 6000000 -940000 5400000
23 Indogulf Cropsciences Limited Smt. Anshu Aggarwal Director Interest paid 90000 NIL 150000 0 0
24 Indogulf Cropsciences Limited Indo Organics Private Limited Sister Concern Sale of goods or services 100000000 NIL 35380000 153710000 104950000
25 Indogulf Cropsciences Limited Glownet Sciences Limited Associate Concern Sale of goods or services 50000000 NIL 520000 1510000 2190000
26 Indogulf Cropsciences Limited AbhiPrakash Globus Pvt Ltd Wholly Subusidiary Sale of goods or services 100000000 NIL 53220000 84700000 88610000
27 Indogulf Cropsciences Limited Max Indo Private Ltd. Associate Concern Purchase of goods or services 50000000 NIL 8890000 15750000 3270000
28 Indogulf Cropsciences Limited AbhiPrakash Globus Pvt Ltd Wholly Subusidiary Any other transaction Rental Income 10000000 NIL 300000 0 320000
29 Indogulf Cropsciences Limited Abhiprakash Infra Private Limited Associate Concern Any other transaction Rental Income 10000000 NIL 120000 180000 320000
30 Indogulf Cropsciences Limited Anshu Aggarwal Director Loan 50000000 NIL 800000 0 0 Loan 0.09 1 Unsecured Buisness Purpose
31 Indogulf Cropsciences Limited Om Parkash Aggarwal Director Loan 50000000 NIL 400000 0 0 Loan 0.09 1 Unsecured Buisness Purpose
32 Indogulf Cropsciences Limited Sanjay Aggarwal Director Loan 50000000 NIL 3000000 0 0 Loan 0.09 1 Unsecured Buisness Purpose
33 Indogulf Cropsciences Limited Indogulf Cropsciences Australia PTY Ltd. Wholly Subusidiary Advance 10000000 NIL 440000 8930000 9380000
34 Indogulf Cropsciences Limited Abhiprakash Globus Pvt. Ltd. Wholly Subusidiary Advance 50000000 NIL 8400000 15250000 24610000
35 Indogulf Cropsciences Limited Indo organics pvt ltd Sister Concern Advance 100000000 NIL 60700000 0 60700000
36 Indogulf Cropsciences Limited Glownet Sciences Private Limited Associate Concern Advance 5000000 NIL 1910000 0 1910000
37 Indogulf Cropsciences Limited Glownet Sciences Private Limited Associate Concern Any other transaction Other 5000000 NIL 70000 0 0
38 Indogulf Cropsciences Limited Abhiprakash Globus Pvt. Ltd. Wholly Subusidiary Any other transaction Expenses Recovered 100000000 NIL 1550000 30000 1590000
39 Indogulf Cropsciences Limited Abhiprakash Globus Pvt. Ltd. Wholly Subusidiary Any other transaction Usage Charges 15000000 NIL 1100000 0 1280000
40 Indogulf Cropsciences Limited Arunika Wife of CFO Any other transaction Salary 1000000 NIL 550000 90000 90000
41 Indogulf Cropsciences Limited Arnav Aggarwal Son of Director Any other transaction Salary 1000000 NIL 300000 50000 50000
42 Indogulf Cropsciences Limited Sanjay Aggarwal INDOGULF Purchase of goods or services 0 NIL 0 0 0
43 Indogulf Cropsciences Limited Sanjay Aggarwal HUF Director's HUF Sale of goods or services 0 NIL 0 0 0
44 Indogulf Cropsciences Limited Glownet Sciences Private Limited Associate Concern Any other transaction Expenses Paid 1000000 NIL 80000 0 0
45 Indogulf Cropsciences Limited Sanshi Aggarwal Director's Daughter Any other transaction Training and development 1000000 NIL 600000 0 0
46 Indogulf Cropsciences Limited Abhiprakash Globus Pvt. Ltd. Wholly Subsidiary Interest received 90000 NIL 1070000 0 0
47 Indogulf Cropsciences Limited Glownet Sciences Private Limited Associate Concern Interest received 90000 NIL 60000 0 0
48 Indogulf Cropsciences Limited Sanjay Aggarwal HUF Director's HUF Any other transaction Capital Advance against property 50000000 NIL 0 23000000 23000000
Total value of transaction during the reporting period 217120000